Member Login
  1. Stocks
    2. /
  2. Bellus Health (TSX: BLU)
    3. /

TSX:BLU (Bellus Health)

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bellus Health (TSX: BLU) Latest News

    Investing

    3 Growth Stocks up Over 50% in 2022

    | Ambrose O'Callaghan

    Canadians on the hunt for growth stocks in should look to equities like Sierra-Wireless Inc. (TSX:SW)(NASDAQ:SWIR) and others today.

    Read more »

    A person builds a rock tower on a beach.
    Dividend Stocks

    3 Stocks To Keep Your Retirement Savings Growing Faster Than Inflation

    | Adam Othman

    The right mix of growth stocks can help you outpace inflation, on the road to retirement.

    Read more »

    Biotech machine with the text “Top Biotech Stocks in Canada” and The Motley Fool jester cap logo
    Page

    Top Biotech Stocks in Canada of 2026

    | Steven Porrello

    In 2025, the Canadian biotech sector saw renewed momentum, with investor interest and funding rebounding. The second half of 2024…

    Read more »

    A worker uses a laptop inside a restaurant.
    Investing

    3 Simple TSX Stocks to Buy With $25 Right Now

    | Adam Othman

    Investing, even if you have minimal capital to invest with, is a good habit. It prevents your savings (in cash)…

    Read more »

    Investing

    TFSA Investors: 3 Stocks That Haven’t Lost Money in 2022

    | Adam Othman

    Many investors have lost money since the beginning of the year due to a market-wide slump. However, there are still…

    Read more »

    Investing

    Parabolic Returns in 2022 Are Possible From 3 Growth Stocks

    | Christopher Liew, CFA

    Three TSX growth stocks could still deliver parabolic returns in 2022, despite inflationary pressures.

    Read more »

    Biotech stocks
    Coronavirus

    Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

    | Amy Legate-Wolfe

    The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

    Read more »

    TSX Today
    Metals and Mining Stocks

    TSX Today: What to Watch for in Stocks on Tuesday, December 14

    | Jitendra Parashar

    TSX stocks might open on a mixed note Tuesday following a choppy movement in the commodities market early this morning.

    Read more »

    Coronavirus

    Why BELLUS Health Exploded 60% on Monday

    | Amy Legate-Wolfe

    BELLUS Health (TSX:BLU)(NASDAQ:BLU) shares soared after positive results from its recent trial for the treatment of chronic cough.

    Read more »

    Investing

    The 50% Healthcare Index Dip and a Silver Lining

    | Adam Othman

    The individual elements/companies within the healthcare sectors move in less harmony than most other sectors, but a huge sector-wide discount…

    Read more »

    Stocks for Beginners

    2 Canadian Healthcare Stocks That Are All-Stars in the Making

    | Daniel Da Costa

    These two top Canadian healthcare stocks are both analyst favourites and offer some of the best growth potential of any…

    Read more »

    Stocks for Beginners

    4 Canadian Stocks That Could Soar 68% or More According to Bay Street

    | Daniel Da Costa

    If you're looking for Canadian growth stocks to buy, these four Canadian companies are some of the best opportunities on…

    Read more »